Alaunos Therapeutics Share Price (NASDAQ: TCRT)

$2.11

▲

0.01

(0.48%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Alaunos Therapeutics Stock chart to analyse performance

Alaunos Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.10
Today's High:$2.28
$2.11
0.47%
Downside
Day's Volatility :7.89%
Upside
7.46%
52 Weeks Low:$1.31
52 Weeks High:$6.20
$2.11
37.74%
Downside
52 Weeks Volatility :78.81%
Upside
65.97%

Alaunos Therapeutics Stock Returns

Period	Alaunos Therapeutics Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-20.37%	3.6%	0.0%
6 Months	36.94%	-7.7%	0.0%
1 Year	-17.94%	-12.6%	0.0%
3 Years	-99.52%	9.5%	-4.7%

Alaunos Therapeutics Inc. Key Stats

Check Alaunos Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.1
Open	$2.1
Today's High	$2.28
Today's Low	$2.1
Market Capitalization	$4.2M
Today's Volume	$55.2K
52 Week High	$6.2
52 Week Low	$1.3137
Revenue TTM	$6.0K
EBITDA	$-4.0M
Earnings Per Share (EPS)	$-2.47
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-107.45%

Stock Returns calculator for Alaunos Therapeutics Stock including INR - Dollar returns

The Alaunos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alaunos Therapeutics investment value today

Current value as on today

₹86,751

Returns

₹13,249

(-13.25%)

Returns from Alaunos Therapeutics Stock

₹18,533 (-18.53%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Alaunos Therapeutics Stock

69%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Alaunos Therapeutics Stock from India on INDmoney has increased by 69% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Alaunos Therapeutics Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
1.03%
Vanguard Group Inc
1.01%
Geode Capital Management, LLC
0.75%
UBS Group AG
0.38%
Tower Research Capital LLC
0.05%
Morgan Stanley - Brokerage Accounts
0.04%

Analyst Recommendation on Alaunos Therapeutics Stock

Rating

Trend

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Alaunos Therapeutics(by analysts ranked 0 to 5 stars)

Alaunos Therapeutics Share Price Target

What analysts predicted

Downside of 17.06%

Target:

$1.75

Current:

$2.11

Alaunos Therapeutics share price target is $1.75, a slight Downside of 17.06% compared to current price of $2.11 as per analysts' prediction.

Alaunos Therapeutics Stock Insights

Price Movement
In the last 7 days, TCRT stock has moved up by 21.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 4.0K → 2.0K (in $), with an average decrease of 50.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.07M → -1.05M (in $), with an average increase of 2.1% per quarter
TCRT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 86.9%
TCRT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.0%
Price to Sales
ForTCRT every $1 of sales, investors are willing to pay $537.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Alaunos Therapeutics Technicals Summary

Sell

Neutral

Buy

Alaunos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Alaunos Therapeutics Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alaunos Therapeutics Inc.	-24.56%	36.94%	-17.94%	-99.52%	-18.25%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	1.77%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alaunos Therapeutics Inc.	NA	NA	NA	0.0	-1.07	-0.54	NA	1.77
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alaunos Therapeutics Inc.	Sell	$4.2M	-18.25%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Alaunos Therapeutics Inc.

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Organization	Alaunos Therapeutics
Employees	1
CEO	Mr. Holger Weis CPA
Industry	Healthcare

Key Management of Alaunos Therapeutics Inc.

Name	Title
Mr. Holger Weis CPA	Chairman of the Board & CEO
Mr. Ferdinand Groenewald	Vice President of Finance

Important FAQs about investing in TCRT Stock from India :

What is Alaunos Therapeutics share price today?

Alaunos Therapeutics share price today is $2.11 as on August 30, 2025 at 1:29 am IST at the close of the market. Alaunos Therapeutics share today touched a day high of $2.28 and a low of $2.10.

What is the 52 week high and 52 week low for Alaunos Therapeutics share?

Alaunos Therapeutics share touched a 52 week high of $6.20 and a 52 week low of $1.31. Alaunos Therapeutics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $2.11, lower by 65.97% versus the 52 week high.

How to invest in Alaunos Therapeutics Stock (TCRT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alaunos Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alaunos Therapeutics Shares that will get you 0.7109 shares as per Alaunos Therapeutics share price of $2.11 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alaunos Therapeutics Stock (TCRT) from India?

Indian investors can start investing in Alaunos Therapeutics (TCRT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Alaunos Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Alaunos Therapeutics share’s latest price of $2.11 as on August 30, 2025 at 1:29 am IST, you will get 4.7393 shares of Alaunos Therapeutics. Learn more about fractional shares .

What are the returns that Alaunos Therapeutics has given to Indian investors in the last 5 years?

Alaunos Therapeutics stock has given -18.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?